Patheon API Services Inc. has applied to the Drug Enforcement Administration (DEA) to become a registered bulk manufacturer of certain controlled substances. This registration is intended to support the clinical trials of their customers. Interested parties are invited to submit comments or objections electronically through the Federal eRulemaking Portal by June 17, 2025. They may also request a hearing on the application by the same date.
Simple Explanation
Patheon API Services Inc. wants to make some special medicines and needs permission from a government group called the DEA. People can say what they think about this or ask for a meeting about it before June 17, 2025.